Atazanavir/ritonavir + lamivudine/zidovudine - Mylan pharmaceuticals
Alternative Names: Atazanavir/ritonavir + zidovudine/lamivudine - Mylan pharmaceuticals; Ritonavir/atazanavir + lamivudine/zidovudine - Mylan pharmaceuticals; Ritonavir/atazanavir + zidovudine/lamivudine - Mylan pharmaceuticalsLatest Information Update: 11 Dec 2018
At a glance
- Originator Mylan Pharmaceuticals
- Class Amides; Antiretrovirals; Azides; Carbamates; Deoxyribonucleosides; Dideoxynucleosides; Oligopeptides; Pyridines; Pyrimidine nucleosides; Small molecules; Thiazoles
- Mechanism of Action HIV protease inhibitors; Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Submission Withdrawal HIV-1 infections
Most Recent Events
- 11 Dec 2018 Chemical structure information added